Now Digital
iPad
Volume 24 • Number 4
APRIL 2013
FEBRUARY 2012
EUROPE EDITION APAO EDITION
THE OFFICIAL NEWS PUBLICATION OF THE ASIA�PACIFIC ACADEMY OF OPHTHALMOLOGY
Effective Rate Date: January 2013 for all advertisers.
Digital
Volume 23 • Number 2 Healio.com/Ophthalmology
2013 Rate Card
®
COVERSTORY STORY COVER
Continuous evolution of endothelial keratoplasty Breakthrough studies revive discussion of changes fieldtreatment of corneal transplantation anti-VEGF regimens for AMD
RATES 1.
Image: Wong TY
Frequency Tien Yin Wong, MD, said monthly injections are most ective Gerrit Melles, MD, eff is the for AMD treatment but are developer of endothelial an ‘unsustainable burden’ on keratoplasty, which today patients, physicians and health represents one to two thirds of care.
Image: Melles G
Anti-VEGF therapy has have been a intromajor Lamellar techniques breakthrough in the treatment duced a paradigm shift inof agecorrelated macular degeneration. neal transplantation. Endothelial Five years after the approval of keratoplasty has undergone rapid the blockbuster drug Lucentis advancements in the last decade, (ranibizumab, Novartis/Genentech) becoming most commonly with the the pivotal MARINA and performed transplantation ANCHOR corneal trials, its sister drug Avasprocedure in the West and relegattin (bevacizumab, Roche/Genentech) ing haspenetrating taken a new keratoplasty turn followingtothea minor resultsrole. of the CATT. Meanwhile, Eylea Inibercept, 1997, Bayer/Regeneron), Gerrit Melles, MD, (afl also started deep lamellar endoknown with as VEGF Trap-Eye, has undergone the phase 3 VIEW I and thelial keratoplasty as the firstVIEW techII trials, has been by the nique to replace theapproved endothelium. U.S. and Drug was Administration “ThFood is technique relatively and has beenso submitted for European demanding, we continued with Union marketstripping approval. endothelial Descemet’s While welcoming new therakeratoplasty in 2001, the in which only pies as one of the most signifi the host Descemet’s membrane cant had continued on page 11 to be excised instead of a posterior
6x
9x
12x
24x
Full Page
$5,500
$5,390
$5,310
$5,225
$5,145
Half Page
3,800
3,725
3,670
3,610
3,555
the total number of keratoplasty procedures in western countries.
continued on page 10
Distribution:
1x
24,943
Visit OSNE.Healio.com Advertising Office: SLACK Incorporated Patrick Duffey Vice President, Sales & Marketing
[email protected], ext. 262
2. Rates: All prices quoted are in U.S. dollars. a) Earned rates are given to advertisers (parent company and its subsidiaries) based on the total number of pages within a 12-month period. A spread counts as two pages. b) Agency commission: Fifteen percent gross billings on space, color, cover, and preferred position charges. c) Cash discount: Two percent if paid within ten days of invoice date. No discount allowed after this period. 3. Bleed: No charge
4. Special Positions: Page 1: Earned b/w rate plus 50%. Page 3: Earned b/w rate plus 25%. Page 5: Earned b/w rate plus 15%. Pages 7 & 9: Earned b/w rate plus 10%. 5. Online Advertising Rates: Please contact your sales representative for more information. 6. Recruitment/Classified Rates: Please contact your regional sales representative at +1-856-848-1000 for information on available opportunities.
Scott Wright Global Sales Director, Eye Care Group
[email protected], ext. 363 Jenna Gentile National Account Manager
[email protected], ext. 359 Carolyn Boerner Director of Sales Administration & Support
[email protected], ext. 355 6900 Grove Road • Thorofare, NJ 08086-9447 856-848-1000 • 800-257-8290 • Fax 856-848-6091 European Advertising Office: The Point of Difference Limited Dick Bower, Jeff Wood European Sales Representatives
[email protected] 4 Chase Side Avenue • London, SW20 8LU United Kingdom +44 (0)20 8542 3200 • Fax +44 (0)20 8543 3810
Healio.com/Ophthalmology
20
Effective Rate Date: January 2013 for all advertisers.
2013 Rate Card: Digital
Discounts 1. Combined Earned Frequency: All insertions of a parent company and its subsidiaries are combined to determine the earned rate. Advertisers may combine space units run in all SLACK publications to achieve maximum rate frequency. 2. Global Continuity Incentive: Advertisements for an individual product are eligible for a discount based upon the number of insertions placed in SLACK publishing’s eye care newspapers (all global editions of Ocular Surgery News plus Primary Care Optometry News). Insertions do not need to be consecutive. This program may not be combined with the Comprehensive Marketing Incentive. a) 3-6 insertions: 10% off b) 7-12 insertions: 15% off c) 13+ insertions: 20% off 3. Comprehensive Marketing Incentive: Advertisers may be eligible for a customized incentive program based upon a total 2013 investment in promotional, marketing and educational services provided through all global print and online editions of SLACK publishing’s eye care newspapers Ocular Surgery News and Primary Care Optometry News and/or associated live nonCME educational events. Contact your sales representative for details. 4. SLACK Corporate Discount: Take advantage of SLACK’s advertising, custom publishing, event management and other marketing services in 2013 and earn valuable discounts in 2014. Spend levels achieved in the year 2013 will determine your Corporate Discount savings in 2014 based on a total net spend. 5. Online/Print Synergy Program: Advertisers who take advantage of Healio. com’s advertising options will earn credit toward their print advertising earned frequency rate. Credit towards higher earned frequency is as follows: a) One month Section Roadblock advertising counts as one ad page toward earned frequency b) Each Newswire advertisement counts as one ad page toward earned frequency There is no cap on earned credits toward print frequency level. Online valueadded does not award credit toward print earned frequency.
6. When taking advantage of more than one discount program, discounts must be taken in the following order: Gross Cost: a) Less Global Continuity Incentive or Comprehensive Marketing Incentive b) Less SLACK Corporate Discount c) Less 15% Agency Discount Equals Net Cost
ISSUANCE AND CLOSING 1. Established: 1990 2. Frequency: 10 times/year 3. Issue Dates: See editorial calendar 4. Extensions and Cancellations: a) Extensions: If an extension date for material is agreed upon and material is not received by the Publisher on the agreed date, the advertiser will be charged for the space reserved. b) Cancellations: If, for any reason, an advertisement is canceled after the closing date, the Publisher reserves the right to repeat a former ad at full rates. If the advertiser has not previously run an ad, the advertiser will be charged for the cost of space reserved. Neither the advertiser nor its agency may cancel advertising after the closing date.
EDITORIAL 1. General Editorial Direction: Ocular Surgery News Europe Edition is an online digital-only medical newspaper for ophthalmologists, providing timely coverage of scientific meetings and events, with special emphasis on cataract/IOL, refractive surgery, glaucoma treatment, retina/vitreous, ophthalmic laser therapy, clinical anterior segment issues and developments affecting the practice of ophthalmology. Every issue features an in-depth cover story on hot-button issues, an In the Journals section that summarizes all the latest journal news, and expert perspectives to put all the news in context, in addition to all of the comprehensive meeting and news coverage readers have come to expect. 2. Average Issue Information: a) Average number of articles per issue: 8-10 b) Average article length: 800 words c) Editorial departments/features: • Cover Story • Complications Consult • Back to Basics 3. Origin of Editorial: a) Staff written: 60% b) Solicited: 20% c) Submitted: 20% d) Articles or abstracts from meetings or other publications: None e) Peer review: None
Healio.com/Ophthalmology
21
Effective Rate Date: January 2013 for all advertisers.
2013 Rate Card: Digital
CIRCULATION
GENERAL INFORMATION
1. Demographic Selection Criteria: a) Age: N/A b) Prescribing: N/A c) Circulation distribution: Controlled: 100% Paid: 0% 2. Estimated total distribution for 2013: 24,943/issue
1. Requirements for Advertising Acceptance: Professional and non-professional products or services are accepted, provided they are in harmony with the policy of service to the health care profession and subject to Publisher’s approval. Non-professional product and service advertisers must submit ad copy two weeks prior to closing date. 2. New Product Releases: Accepted on a space available basis. Please submit to your sales representative. 3. Ad Format Placement Policy: a) Format: Within articles b) Are ads rotated?: Yes 4. Ad/Edit Information: 40/60 Ad/Edit Ratio 5. Value-Added Services: a) Ad test: Nov/Dec 6. Online Advertising Opportunities: Contact your sales representative or visit Healio.com/Ophthalmology for more information. 7. Additional Advertising Opportunities: a) Split-run advertising: Contact publisher for information. 8. Reprint Availability: Yes, email
[email protected].
9. Publisher’s Liability: The Publisher shall not be liable for any failure to print, publish or circulate all or any portion of any issue in which an advertisement accepted by the Publisher is contained if such failure is due to acts of God, strikes, war, accidents or other circumstances beyond the Publisher’s control. 10. Indemnification of Publisher: In consideration of publication of an advertisement, the advertiser and the agency, jointly and separately, will indemnify, defend, and hold harmless the publication, its officers, agents, and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including without limitation, claims or suits for libel, violation of right of privacy, copyright infringements or plagiarism. 11. Competitor Information: Ocular Surgery News Europe Edition does not accept advertisements that contain competitor(s’) names, publication covers, logos or other content. 12. Advertorials: In order to be considered for acceptance, advertisements or inserts which contain text or copy describing a product or surgical technique, must be substantially different in text and font of the receiving publication and the word “Advertorial” or “Advertisement” will be prominently displayed in 10 point, black type, in ALL CAPS at the top of the ad. 13. Billing Policy: Billing to an advertising agency is based on acceptance by the advertiser of “dual responsibility” for payment if the agency does not remit within 90 days. The Publisher will not be bound by any conditions, printed or otherwise, appearing on any insertion order or contract when they conflict with the terms and conditions of this rate card.
Healio.com/Ophthalmology
22
Effective Rate Date: January 2013 for all advertisers.
2013 Rate Card: Digital
Ad Specifications 1. Available Advertising Unit Sizes: Ad sizes:
Inches Width
Height
Centimeters Width
Height
4.125" x 6.1875" 10.4775 cm x 15.7163 cm Full Page 4.125" x 3" 10.4775 cm x 7.62 cm Half Page Horizontal Trim size of publication: 4.125” x 6.1875” (10.4775 cm x 15.7163 cm) 2. File format: High resolution PDF/X-1A (300 dpi) 3. Links: Please supply all urls you want linked in the ad. 4. Disposition of Ad Material: Ad materials will be held for one year from date of last insertion and then destroyed unless instructed otherwise in writing.
Video Specifications 1. Video Format excepted: mp4, mpg, mpeg, mov, ogv, ogg, wmv, avi, flv All video formats will be converted to a FLV video file. FLV to MP4 file for view on mobile devices that do not support FLASH (50mb max size).
aUDIO Specifications
contact information
1. File Format: .mp3 only (50mb max size)
Send product insertion orders and ad materials to: Carolyn Boerner
Animated Ad Specifications
OSN Europe Edition/Issue Month c/o SLACK Incorporated 6900 Grove Road Thorofare, NJ 08086-9447, USA
[email protected] +1-856-848-1000 x355 Fax: +1-856-848-6091
Director of Sales Administration & Support
1. Advertisers MUST supply a static placeholder file in addition to an animated file. Ad sizes:
Animated File Dimensions
Placeholder Ad Size
Width Height Width Height 594 px x 891 px 4.125” x 6.1875” Full Page 594 px x 432 px 4.125” x 3” Half Page Horizontal 2. File format: .flv, .swf or .mp4 (50mb max size) 3. Action Script: 3.0 only NOTE: SWFs and FLVs are viewable on Desktop platform but not all mobile devices. 4. Placeholder format: High resolution PDF/X-1A (300 dpi) 5. Links: Please supply all urls you want linked in the ad. 6. Disposition of Ad Material: Ad materials will be held for one year from date of last insertion and then destroyed unless instructed otherwise in writing.
Healio.com/Ophthalmology
23
